News | September 15, 2020

CuraSen Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial with First Proprietary Compound, CST-2032, Targeting Neurodegenerative Disease Novel Approach Aimed at Restoring Brain Functionality September 15, 2020 — San Mateo, Calif.—CuraSen...

News | September 1, 2020

TigerConnect Acquires Call Scheduler, Launches Fully-Integrated TigerSchedule™ to Simplify Physician On-Call Scheduling Acquisition bolsters collaboration across complex healthcare teams to drive efficiency in the COVID-19 era SANTA MONICA, Calif. — Sept. 1, 2020 —...

News | September 15, 2020

Adventist Health Enhances Online Access for Both New and Existing Patients with Kyruus and Cerner Collaboration by Kyruus, on Sep 15, 2020 9:00:00 AM California-Based Health System is First to Offer Kyruus ProviderMatch® Integrated with the Cerner Consumer FrameworkTM...

News | August 10, 2020

Saniona successfully raises USD 65 million (approximately SEK 567 million) in a directed issue of shares NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE...

News | September 14, 2020

ESCAPE BIO CLOSES $73 MILLION IN CROSSOVER FINANCING TO ADVANCE CLINICAL DEVELOPMENT OF PRECISION NEUROLOGY MEDICINES FOR GENETIC NEURODEGENERATION – ESCAPE BIO SOUTH SAN FRANCISCO, September 14, 2020 — ESCAPE Bio, a clinical stage company developing novel, precisely...